IsoRay’s Cesium-131 Cancer Treatment Takes Center Stage at Weill Cornell’s International Symposium “Advances in Brachytherapy”

IsoRay’s Cesium-131 Cancer cells Therapy Takes Spotlight at Weill Cornell’s International Symposium “Breakthroughs in … 12:36 GMT Successful Cesium-131 Cancer Therapy Outcomes, Methods as well as Patient Selection Criteria Existed in a Peer to Peer Forum of Leading Medical Professionals RICHLAND, WA–(Marketwired – May 11, 2015) – IsoRay, Inc. (NYSE [...] Read More